These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 18579222)

  • 21. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of bone marrow renin-angiotensin system in the pathogenesis of atherosclerosis.
    Fukuda D; Sata M
    Pharmacol Ther; 2008 May; 118(2):268-76. PubMed ID: 18439685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Respective roles of cortisol, aldosterone and angiotensin II during pathophysiology of atherosclerosis].
    Ayari H
    Ann Biol Clin (Paris); 2013; 71(4):381-8. PubMed ID: 23906564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARalpha activator fenofibrate modulates angiotensin II-induced inflammatory responses in vascular smooth muscle cells via the TLR4-dependent signaling pathway.
    Ji YY; Liu JT; Liu N; Wang ZD; Liu CH
    Biochem Pharmacol; 2009 Nov; 78(9):1186-97. PubMed ID: 19576184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of renin-angiotensin system in the pathogenesis of atherosclerosis].
    Hirata Y; Fukuda D; Sata M
    Nihon Rinsho; 2009 Apr; 67(4):707-13. PubMed ID: 19348232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The involvement of the renin-angiotensin system (RAS) in cancerogenesis].
    Domińska K; Lachowicz-Ochedalska A
    Postepy Biochem; 2008; 54(3):294-300. PubMed ID: 19112828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II and oxidative stress.
    Hitomi H; Kiyomoto H; Nishiyama A
    Curr Opin Cardiol; 2007 Jul; 22(4):311-5. PubMed ID: 17556883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
    David S; Kümpers P; Lukasz A; Kielstein JT; Haller H; Fliser D
    J Hypertens; 2009 Aug; 27(8):1641-7. PubMed ID: 19390459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines and renin-angiotensin system signaling in hepatic fibrosis.
    Moreno M; Bataller R
    Clin Liver Dis; 2008 Nov; 12(4):825-52, ix. PubMed ID: 18984469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the renin-angiotensin system in vascular diseases: expanding the field.
    Ruiz-Ortega M; Lorenzo O; Rupérez M; Esteban V; Suzuki Y; Mezzano S; Plaza JJ; Egido J
    Hypertension; 2001 Dec; 38(6):1382-7. PubMed ID: 11751722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y; Jacob RF; Mason RP
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II and the development of insulin resistance: implications for diabetes.
    Olivares-Reyes JA; Arellano-Plancarte A; Castillo-Hernandez JR
    Mol Cell Endocrinol; 2009 Apr; 302(2):128-39. PubMed ID: 19150387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the renin-angiotensin system and target organ protection.
    Iwanami J; Mogi M; Iwai M; Horiuchi M
    Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
    Koga J; Egashira K; Matoba T; Kubo M; Ihara Y; Iwai M; Horiuchi M; Sunagawa K
    Hypertens Res; 2008 Sep; 31(9):1791-800. PubMed ID: 18971558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system.
    Groeschel M; Braam B
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F1-10. PubMed ID: 20980410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.